BACKGROUND: Several studies support the hypothesis that oxidation of low-density lipoprotein (LDL) promotes atherogenesis. Obesity is one of the risk factors of atherosclerosis, but it is not known whether obesity is related to LDL oxidation. OBJECTIVE AND DESIGN: We investigated the effect of weight reduction and subsequent weight maintenance program on LDL oxidation in 77 obese premenopausal women (BMI 29 ± 46 kgam 2 ). Another group of seven obese women served as a control group. Oxidized LDL was measured as baseline concentration of conjugated dienes in LDL lipids (ox-LDL). The weight reduction was performed in 12 weeks, using a very-low-energy diet. RESULTS: The mean weight loss was 13 kg (92 vs 79 kg). During weight reduction, the concentration of LDL cholesterol decreased by 11%, the concentration of ox-LDL decreased by 40%, and the ratio of ox-LDL to LDL by 33%. The concentration of LDL antioxidant capacity (LDL-TRAP) decreased by 8%, but the decrease was caused by the decrease in LDL. The concentration of LDL, ox-LDL or LDL-TRAP did not change in the control group. The weight reduction correlated with the decrease of ox-LDL. During the subsequent 9 month weight maintenance programme, the concentrations of serum LDL (10%), ox-LDL (11%), LDL-TRAP (29%), and the ratio of LDL-TRAP to LDL (21%) decreased. CONCLUSION: This study strengthens the evidence that the risk of atherogenesis is in¯uenced favourably by weight reduction in obese women. This risk reduction is associated with a reduced oxidation of LDL.
Introduction
The prevalence of obesity in many developed countries has increased during recent decades. In the USA this is particularly true for women. 1 Obesity has several co-morbidities, including coronary heart disease (CHD), hypertension and adult-onset diabetes, 2 and it is an independent risk factor for both incidence and mortality of CHD. 3 ± 7 On the other hand, reduction of body weight decreases the concentration of serum cholesterol and low-density lipoprotein (LDL) cholesterol. 8 Several studies support the hypothesis that oxidation of LDL promotes atherogenesis, 9 ± 11 and LDL oxidation is associated with the severity of coronary atheroschlerosis. 12 The oxidative modi®cation of LDL is assumed to occur extravascularly in the arterial intima. 9, 10 However, a major part of LDL entering the artery wall will re-enter circulation and there is evidence for the existence of circulating oxidized LDL. 13, 14 Mildly oxidized LDL may circulate in plasma long enough to enter, accumulate and be degraded in the arterial intima. 15 Unlike highly oxidized LDL, such minimally modi®ed LDL is taken up by LDL receptors rather than by scavenger receptors. 16 As a further indication of the existence of circulating oxidized LDL, it was recently found that vascular endothelial cells have a speci®c receptor for oxidized LDL. 17, 18 Several risk factors of atherosclerosis have been studied also with respect to their possible effects on LDL oxidation. Yet, the role of obesity and weight reduction have received little attention. In this study, we investigated the effect of 12 weeks' weight reduction and a subsequent 9 month weight-maintenance programme (including aerobic exercise for two thirds of the subjects) on LDL oxidation in 77 premenopausal obese women. Another group of seven obese women were used as a control group. As an indicator of LDL oxidation we determined the baseline concentrations of conjugated dienes in lipids extracted from LDL (ox-LDL), 19 which are suggested to re¯ect circulating concentrations of minimally oxidized LDL.
Methods

Subjects
We studied 77 obese premenopausal women volunteers in the weight reduction and weight maintenance (WR WM) groups and seven obese women in the control group. The subjects were recruited through advertisements in a local newspaper. The inclusion criteria were premenopausal woman, body mass index (BMI) of 29 kgam 2 or above, no regular medication (except contraceptives), no ischemic ECG changes in a maximal treadmill test, no musculoskeletal or other contraindications to walking training, stable weight ( AE 3 kg) during the previous 6 months, normal lipid pro®le, no signs of a binge-eating syndrome, little regular exercise (less often than twice a week), non-smoking, non-pregnant and no intention of becoming pregnant during the next 3 y. The subjects gave written informed consent after having the purpose, possible risks, and stress associated with the study explained to them. The mean (range) values of the following variables describing the enrolled subjects were: age 40.2 (29 ± 46) y, height 164.4 (153 ± 176) cm, body mass 92.1 (75 ± 126) kg, and BMI 34.1 (29 ± 46) kgam 2 . The study was conducted according to the guidelines of an independent ethical committee and the Declaration of Helsinki.
Study design
In the WR WM groups, the subjects ®rst completed a 12 week weight-reduction phase, after which they were randomized into one of the following three groups for 9 months: high exercise (4 ± 6 h walkingaweek; n 25), low exercise (2 ± 3 h walkingaweek; n 24), and dietary counselling (n 28). The intention of the walking training was to generate an energy expenditure of 4.2 MJaweek (low exercise) or 8.4
MJaweek (high exercise). The weight reduction programme consisted of three phases according to the American Dietetic Association:
20 week 1 Ð LED (low-energy diet), based on a meal-exchange system; weeks 2 ± 9 Ð VLED (very low-energy diet, Nutrilett 1 , Nycomed Pharma AS, Oslo, Norway); and weeks 10 ± 12 Ð LED. VLED was prescribed to cover 40% of measured resting energy expenditure. The estimated daily energy and fat intakes were calculated from 4 day food records, collected six times during 12 months, by the Micronutrica 1 software (The Social Insurance Institution, Turku, Finland, Table 1 ).
During the weight-reduction phase, the subjects met weekly in small groups facilitated by a nutritionist. The meeting topics included instructions on how to follow LED and VLED, general knowledge on diet and weight maintenance, and relapse-prevention techniques. All subjects were weighed before each session.
Supervised exercise sessions were held for the two exercise training groups once a week. During the sessions, the subjects returned their previous week's training diary. The number of daily steps for 7 days was measured by a pedometer (Fitty 3, Electronic Pedometer, Kasper & Richter, Uttenreucht, Germany) once during the weight reduction (2 months) and once in the end of the weight-maintenance phase (12 months).
The control group was studied twice (0 and 3 months) without any interventions during the same study months as the weight reduction was performed in the WR WM groups. The control group participated only in body weight and height measurements and analyses of LDL oxidation and LDL antioxidant potential.
Venous blood samples were obtained at 8:00 ± 9:00 am after 12 h of fasting before the weight reduction (0 months), and before (3 months) and after (12 months) the weight maintenance programme in the active groups and twice in the control group (0 and 3 months). Serum was separated by centrifugation (10 min, 4 C, 3000 rpm), after which it was stored at À70 C until analysis.
Analytical methods
Serum cholesterol and triglyceride concentrations were analysed from frozen samples by enzymatic methods (CHOL- Weight reduction and LDL oxidation T Vasankari et al PAP for cholesterol and GPO-PAP for triacylglycerols, Boehringer Mannheim, Mannheim, Germany). HDL cholesterol was determined by selective precipitation (dextran sulphate). 21 Plasma insulin determinations were done by RIA (Phadeseph Insulin, Pharmacia, Uppsala, Sweden). Plasma glucose was assessed by the glucose dehydrogenase method (Merck Diagnostica, Darmstadt, Germany). A Hitachi 717 automatic analyser (Hitachi, Ltd, Tokyo, Japan) and Epos 5060 analyser (Eppendorf, Darmstadt, Germany) were used for the analyses.
As an indicator of LDL oxidation we measured baseline LDL diene conjugation (ox-LDL) by a method which has been recently validated and reported in detail. 19 For this analysis serum low-density lipoproteins were isolated by a precipitation method. 22 The coef®cient of variation (CV) for the within-assay precision (12 determinations of the same serum) of the precipitation phase was 3.6%. After resuspension of the LDL, the concentration of cholesterol was measured using a kit (CHOD-PAP method, Boehringer Mannheim, Mannheim, Germany). Thereafter, lipids were extracted from the LDL samples (100 ml) by chloroform ± methanol (2 : 1), dried under nitrogen, then redissolved in cyclohexane, and analysed spectrophotometrically at 234 nm. Oxidation during the sample preparation was prevented by EDTA. 19 Additionally, baseline diene conjugation values measured in heparin Ð precipitated LDL are not different from those measured in LDL isolated by the conventional ultracentrifugation method. 23 The assay procedure of LDL diene conjugation is not interfered with by, for example, non-steroidal anti-in¯ammatory drugs, statins or vitamin E (unpublished observation). Here the CV for the within-assay precision was 4.4% (20 determinations of the same sample); the CV for the between-assay precision was 4.5% (over a period of 3 months). 19 The antioxidant potential of the LDL samples was assessed in vitro by their potency to resist 2,2 H -azobis(2-amidinopropane) HCl-induced peroxidation (`total peroxyl radical trapping antioxidant potential', LDL-TRAP). 19 The peroxyl radical trapping capacity was de®ned as the half-peak time point. Trolox served as the standard radical scavenger in these assays.
Body composition
The body weight of the subjects was measured on a highprecision scale (Sartorius F150S-D2, Goettingen, Germany). The subjects wore their underwear at the time of weighing which took place after an overnight fast. Body density was measured by underwater weighing, after full exhalation by the subjects (ie presumably at residual lung volume). 24 The residual lung volume was measured two to four times before the underwater weighing, by the helium-dilution method. Body fat was calculated using the underwater body weight according to the equation (two-component model): 25 Body fat Percentage of body weight
Fat mass kg body fat percentagea100 Â weight Waist girth was measured horizontally half-way between the lowest rib and the suprailiac crest.
Statistical analyses
For the statistical calculations BMDP Statistical Software was used. Four main outcomes were studied: (1) the change of the variables measured during the weight-reduction period (0 vs 3 months, paired t-test); (2) the change of the variables Weight reduction and LDL oxidation T Vasankari et al measured during the weight-maintenance period (3 vs 12 months, paired t-test); (3) the effect of walking exercise vs diet on weight maintenance (3 vs 12 months, repeated measures ANOVA); and (4) the association between the change in body fat (kg)aweight (kg) and the variables that describe oxidation (0 vs 3 months, and 3 vs 12 months, Pearson correlations).
Results
During the 12 weeks of weight reduction (0 vs 3 months), the average weight of the subjects decreased by 13.1 kg, the BMI by 4.9 kgam 2 and the body fat by 4% units in the WR WM groups (P`0.0001 for all changes; Table 2 ). At the same time, the serum concentrations of cholesterol, HDL cholesterol and triglyceride decreased by 13%, 7% and 22% (P`0.0001 for all changes), respectively ( Table 3 ). The concentration of LDL cholesterol, ox-LDL and the ratio of ox-LDL to LDL (ox-LDL : LDL ratio) decreased by 11%, 40% and 33% (P`0.0001 for all changes), respectively (Table 4, Figure  1 ). The concentration of LDL-TRAP decreased by 8% (P`0.0001), but the decrease was caused by the reduction in LDL cholesterol, and there was no change in the ratio of LDL-TRAP to LDL cholesterol during the weight-reduction period.
In the control group, the weight of the subjects decreased by 1.8 kg, and the BMI by 0.6 kgam 2 (both, P`0.05) during the 3 months (Table 2) . At the same time, the concentration of LDL cholesterol, ox-LDL and the ox-LDL : LDL ratio did not change (Table 4) , and neither did the concentration of LDL-TRAP and the ratio of LDL-TRAP to LDL cholesterol.
The correlations between the reductions in body weight, fat mass, and ox-LDL and some other variables measured during the 12 weeks of weight reduction are shown in Table  5 . The weight reduction correlated with the decrease in serum cholesterol (r 0.30, P 0.0093), serum triacylglycerols (r 0.39, P 0.0005), ox-LDL (r 0.24, P 0.039), plasma insulin (r 0.39, P 0.0006) and plasma glucose (r 0.29, P 0.010).
There was no difference between the WR WM groups regarding the change of body weight or any other of the metabolic variables measured during the weight maintenance (3 vs 12 months) period. Therefore, the results of weight maintenance are presented for the three active groups combined (Tables 1 ± 4 ). During the weight-maintenance period, the mean body weight remained stable and the concentration of serum cholesterol, HDL cholesterol, triglyceride and plasma insulin increased by 9%, 20%, 22% and 15% (all, P`0.0001), respectively, while serum LDL, ox-LDL, LDL-TRAP and the ratio of LDL-TRAP to LDL decreased by 10% (P`0.0001), 11% (P`0.0008), 29% (P`0.0001) and 21% (P`0.0001), respectively.
During the weight-maintenance phase (3 vs 12 months), there was no correlation between the change of weight or fat mass and the biochemical variables. At the end of the weight-maintenance phase (12 months), ox-LDL correlated positively with the known atherosclerosis risk factors, waist girth (r 0.36, P 0.001) and body fat (r 0.37, P 0.001), but not with number of daily steps (r À0.05, NS).
During the weight-maintenance phase (3 vs 12 months), there was no correlation between the energy and fat intakes Weight reduction and LDL oxidation T Vasankari et al on the one hand and ox-LDL on the other, but the decrease in LDL-TRAP correlated with total fat (r À0.30, P 0.01) and saturated fat intake (r À0.31, P 0.009).
Discussion
We studied the effect of a 12 week weight-reduction and a subsequent 9 month weight-maintenance programme on LDL oxidation in a group of obese premenopausal females. This is apparently the ®rst study to investigate the effects of weight reduction and obesity on LDL oxidation. A 13 kg decrease in body weight was associated with a 40% decrease in minimally oxidized LDL concentration (Table 5) . A 33% decrease in the ox-LDL : LDL ratio also took place. In the control group, where only minor decrease was seen in body weight, no changes were seen in LDL oxidation. The weightmaintenance phase with no further change in weight resulted in no further decrease in the ox-LDL : LDL ratio, but the concentrations of both LDL cholesterol and LDL diene conjugation decreased (by 10 and 11%, respectively). Baseline diene conjugation of LDL lipids is known to be almost exclusively due to conjugated fatty acids of cholesteryl esters and triacylglycerols. 26 Therefore, no major changes were expected in LDL diene conjugation during the weight-maintenance period, since between second LEDphase and the weight-maintenance period dietary intakes of cholesterol and PUFA did not change much ( Table 1) .
The result that a programme of increased physical activity randomized to two-thirds of the subjects after the weightreduction period did not further decrease the ox-LDL : LDL ratio is probably mainly explained by the substantial decrease in this ratio during the preceding weight-reduction period. However, in our earlier study, a 10 month exercise training programme not speci®cally aimed at weight reduction did reduce ox-LDL and the ox-LDL : LDL ratio in sedentary men (by 24 and 13%, respectively) and women (by 26 and 18%). 27 Further, participation in several years of intensive physical training was associated with reduced circulating minimally oxidized LDL (LDL diene conjugation) in veteran endurance athletes in a cross-sectional study. 28 On the other hand, acute, even prolonged, exercise did not affect circulating minimally oxidized LDL in endurance athletes or sedentary men. 29 To achieve the greatest reduction in CHD risk, the goal of obesity reduction programmes should be to maximize fat loss. 30, 31 In the present study, the reduction of body weight Figure 1 Percentual change in the ratio of minimally oxidized LDL cholesterol to LDL cholesterol (ox-LDL : LDL) in the WR WM groups (oval) and the control group (rectangle). WR weight reduction; WM weight maintenance. *Signi®cant change during the weight reduction (P`0.0001). Weight reduction and LDL oxidation T Vasankari et al correlated positively with the reduction in ox-LDL (r 0.24, P 0.039), and the amount of fat mass lost tended to correlate with the decrease of ox-LDL (r 0.22, P 0.057). In accordance to this, the ox-LDL : LDL ratio correlated positively with the weight (r 0.15, P 0.038), the waist circumference (r 0.19, P 0.0096) and the hip circumference (r 0.18, P 0.014) in 183 healthy adolescent girls. 32 The inaccuracy of body composition methods is likely to weaken the relation between body fat and ox-LDL. 24 There was no correlation between the change of serum LDL cholesterol and the reduction of body weight or fat mass (r 0.18, P 0.12 and r 0.07, P 0.53 respectively). Hence, the decrease in ox-LDL seems to be more strongly related to weight reduction than concentration of LDL cholesterol.
Measurement of diene conjugation has become the most popular method to monitor LDL oxidation in vitro, and the oxidation-induced increase of diene conjugation in LDL lipids is well documented. 33, 34 Our method for the direct measurement of minimally oxidized LDL measures the baseline level of diene conjugation in circulating LDL. Recently, we demonstrated an association between circulating minimally oxidized LDL and severity of coronary artery disease: the ox-LDL : LDL ratio was 41% higher in patients with multi-vessel disease compared to the subjects with normal coronary arteries. 26 Another group recently reported a reduction by 21% in baseline LDL diene conjugation in coronary artery disease patients undergoing atherosclerosis-reversal therapy. 35 Further, baseline LDL diene conjugation is associated with arterial elasticity, suggesting that oxidative modi®cation of LDL may play a role in the arterial wall elastic properties. 36 We have also demonstrated a strong correlation (r 0.57, P 0.001) between the concentration of LDL diene conjugation and the autoantibody titer against oxidized LDL.
23
The LDL antioxidant capacity decreased slightly during the weight reduction period, but no changes occurred after adjustment for the decrease of LDL cholesterol. Hence, the 12 week low-energy diet did not change the antioxidant potential in LDL fraction (LDL-TRAP). Surprisingly, LDL-TRAP was reduced by 29% during the weight maintenance period with no further change in weight. Also, the ratio of LDL-TRAP to LDL decreased by 21%. The decrease of LDL antioxidant potential during the weight maintenance correlated negatively with the total fat and saturated fat intake during the weight maintenance: the less fat and especially the less saturated fat was consumed, the more pronounced was the reduction of the antioxidant potential of LDL. Hence, intake of fat seems to be related to LDL antioxidant potential. It is suggested that reduced intake of fat is associated with decreased absorption of fat soluble antioxidative compounds.
Increased consumption of fruits and vegetables increases plasma antioxidant potential. 37 Supplementation doses of vitamin E alone and co-supplementation with other antioxidants increases LDL-TRAP markedly. 19, 38, 39 In the present study, the estimated intake of vitamin E in food was reduced both during the weight reduction and during the weight maintenance. Hence, the decrease of LDL-TRAP during the weight-maintenance period may partly have been caused by prolonged reduced intake of vitamin E. In addition, the increased consumption of antioxidants during the exercise phase while simultaneously the energy intake was restrained may also have contributed to the reduced antioxidant potential.
In conclusion, our study strengthens the evidence that the risk of atherogenesis is in¯uenced favourably by weight reduction in obese women. This risk reduction is associated with a reduced oxidation of LDL.
